Tanja Kuhlmann Selected Research

Tanja Kuhlmann Research Topics

Disease

22	Multiple Sclerosis 01/2023 - 08/2006
17	Demyelinating Diseases (Demyelinating Disease) 01/2023 - 05/2009
12	Inflammation (Inflammations) 04/2024 - 10/2002
8	Disease Progression 01/2023 - 08/2006
6	Neuroinflammatory Diseases 04/2024 - 11/2014
5	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022 - 10/2002
3	Frontotemporal Dementia (Semantic Dementia) 04/2024 - 07/2015
3	Neoplasms (Cancer) 04/2014 - 10/2008
2	Iron Overload 12/2018 - 02/2018
2	Anemia 02/2018 - 01/2016
2	Encephalitis (Encephalitis, Rasmussen) 04/2016 - 12/2013
1	Absence Epilepsy (Childhood Absence Epilepsy) 10/2022
1	Urinary Tract Infections (Urinary Tract Infection) 01/2022
1	Relapsing-Remitting Multiple Sclerosis 11/2021
1	Psychotic Disorders (Schizoaffective Disorder) 11/2020
1	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 11/2020
1	Pathologic Processes 01/2019
1	Multiple System Atrophy 01/2019
1	Encephalomyelitis (Myeloencephalitis) 01/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017
1	Neuromyelitis Optica (Devic's Disease) 01/2017
1	Central Nervous System Diseases (CNS Diseases) 02/2016
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2016
1	Alzheimer Disease (Alzheimer's Disease) 12/2015
1	Colorectal Neoplasms (Colorectal Cancer) 08/2015
1	Dementia (Dementias) 07/2015
1	Paralysis (Palsy) 04/2015
1	Polymyositis 03/2015

Drug/Important Bio-Agent (IBA)

8	CuprizoneIBA 10/2022 - 05/2009
4	IronIBA 01/2019 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 04/2024 - 07/2013
3	Myelin-Oligodendrocyte GlycoproteinIBA 01/2023 - 08/2006
2	PotassiumIBA 01/2023 - 01/2019
2	Integrin alpha4beta1 (VLA-4)IBA 11/2022 - 08/2018
2	Dimethyl FumarateIBA 11/2021 - 09/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021 - 07/2013
2	HepcidinsIBA 12/2018 - 02/2018
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2017 - 07/2015
2	tau Proteins (tau Protein)IBA 01/2017 - 07/2015
2	AntibodiesIBA 01/2017 - 06/2014
2	AntigensIBA 03/2015 - 10/2002
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2010 - 07/2007
1	OsteopontinIBA 04/2024
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2023
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2023
1	Cell Adhesion MoleculesIBA 01/2023
1	GelatinasesIBA 01/2023
1	Matrix Metalloproteinases (MMPs)IBA 01/2023
1	Natalizumab (Tysabri)FDA Link 01/2023
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2023
1	Hyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsIBA 10/2022
1	CytokinesIBA 10/2022
1	nitroxolineIBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	connexin 47IBA 01/2021
1	Connexin 43 (Connexin43)IBA 01/2021
1	Linoleic Acid (Linoleate)IBA 01/2021
1	Conjugated Linoleic AcidsIBA 01/2021
1	AutoantibodiesIBA 11/2020
1	InterferonsIBA 01/2019
1	Myelin Basic ProteinIBA 01/2019
1	SynucleinsIBA 01/2019
1	LigandsIBA 12/2018
1	Coloring Agents (Dyes)IBA 09/2018
1	CD146 AntigenIBA 08/2018
1	Laminin (Merosin)IBA 08/2018
1	IntegrinsIBA 08/2018
1	Type I Bone Morphogenetic Protein ReceptorsIBA 02/2018
1	Hormones (Hormone)IBA 02/2018
1	NFATC Transcription FactorsIBA 01/2018
1	Aquaporins (Water Channels)IBA 01/2017
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2017
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 05/2016
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2016
1	SaltsIBA 02/2016
1	chondroitin sulfate proteoglycan 4IBA 01/2016
1	ferric carboxymaltoseIBA 01/2016
1	Presenilin-1IBA 12/2015
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 08/2015
1	Indomethacin (Indometacin)FDA LinkGeneric 08/2015
1	CateninsIBA 08/2015
1	Kainic Acid (Kainate)IBA 04/2015
1	Alemtuzumab (Campath)FDA Link 03/2015
1	Fibroblast Growth Factor 1 (FGF-1)IBA 12/2014
1	Matrilin ProteinsIBA 11/2014
1	Potassium Channels (Potassium Channel)IBA 06/2014
1	Biomarkers (Surrogate Marker)IBA 02/2014
1	Antigen-Antibody Complex (Immune Complex)IBA 12/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2013
1	Rituximab (Mabthera)FDA Link 12/2013
1	Messenger RNA (mRNA)IBA 10/2013
1	StaurosporineIBA 10/2013
1	CopperIBA 10/2013
1	Chelating AgentsIBA 10/2013
1	Netrin-1IBA 09/2013
1	Shiga Toxin 2IBA 03/2013

Therapy/Procedure

8	Therapeutics 01/2023 - 10/2002
2	Immunotherapy 11/2020 - 01/2020
2	Subcutaneous Injections 04/2014 - 07/2008
1	Oral Administration 04/2015